ResearcherLa Trobe UniversityActive in the last 2 years

Ashleigh R. Poh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8375-4753; OpenAlex author ID A5026797391. Sources: OpenAlex.

Their work

Papers: 6 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: none · 2026: 3 papers

Papers 6

Progress, challenges, and future directions of pancreatic cancer surveillance in high-risk populations. Co-author DOI 10.1038/s43856-026-01822-0 ↗
Progress and challenges in expanding access to clinical trials in pancreatic cancer. Last author DOI 10.1038/s43856-026-01869-z ↗
A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic adenocarcinoma. Co-author DOI 10.1186/s12885-026-16113-z ↗
An intrasplenic injection model of pancreatic cancer metastasis to the liver in mice. Last author DOI 10.1016/j.xpro.2022.102021 ↗
Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities. Co-author DOI 10.1038/s41388-023-02701-x ↗
Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges. Co-author DOI 10.3390/cancers13122860 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Matthias Ernst · 3 shared papers, 2021–2023 · strength 0.97
Andrew J. Metz · 2 shared papers, 2026 · strength 0.67
- Paper Progress and challenges in expanding access to clinical trials in pancreatic cancer. DOI 10.1038/s43856-026-01869-z ↗
- Paper Progress, challenges, and future directions of pancreatic cancer surveillance in high-risk populations. DOI 10.1038/s43856-026-01822-0 ↗
Sue S. Thang · 2 shared papers, 2026 · strength 0.64
- Paper Progress and challenges in expanding access to clinical trials in pancreatic cancer. DOI 10.1038/s43856-026-01869-z ↗
- Paper A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic aden… DOI 10.1186/s12885-026-16113-z ↗
Prasad D. Cooray · 2 shared papers, 2026 · strength 0.64
- Paper Progress and challenges in expanding access to clinical trials in pancreatic cancer. DOI 10.1038/s43856-026-01869-z ↗
- Paper A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic aden… DOI 10.1186/s12885-026-16113-z ↗
Megan O’Brien · 1 shared paper, 2023 · strength 0.31
- Paper An intrasplenic injection model of pancreatic cancer metastasis to the liver in mice. DOI 10.1016/j.xpro.2022.102021 ↗
Vijayaragavan Muralidharan · 1 shared paper, 2026 · strength 0.28
- Paper A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic aden… DOI 10.1186/s12885-026-16113-z ↗
Adrian M. Fox · 1 shared paper, 2026 · strength 0.28
- Paper A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic aden… DOI 10.1186/s12885-026-16113-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.